Mercy Hospital St. Louis - David C. Pratt Cancer Center

Clinical research site in St Louis, Missouri · Mercy David C. Pratt Cancer Center - St. Louis, 607 S New Ballas Rd, St. Louis, MO 63141 · (314) 251-6400 · Website

As of July 2026, 8 paid clinical trials are recruiting at Mercy Hospital St. Louis - David C. Pratt Cancer Center in St Louis, Missouri. Active studies at this site cover conditions such as Ovarian Cancer, Breast Neoplasms and Carcinoma, Ductal, Breast. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Mercy Hospital St. Louis - David C. Pratt Cancer Center (8)

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for Ovarian Cancer

38 locations incl. Anchorage

Sponsor: Incyte Corporation

Sex: Female·Age: 18+

Code: NCT07214779·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

for Breast Neoplasms

39 locations incl. Birmingham

Sponsor: Natera, Inc.

Sex: All·Age: 18+

Code: NCT07214532·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for Non Small Cell Lung Cancer

45 locations incl. Little Rock

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06312137·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

GEMINI-NSCLC: NSCLC Biomarker Study

for Non-Small Cell Lung Cancer

56 locations incl. Birmingham

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT05236114·Recruiting·Listed Feb 2022

Apply to this trial

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

for Recurrent Ovarian Cancer

7 locations incl. Los Angeles

Sponsor: AbbVie

Sex: Female·Age: 18+

Code: NCT06365853·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

for Colorectal Cancer

20 locations incl. Fort Smith

Sponsor: Tempus AI

Sex: All·Age: 18+

Code: NCT05234177·Recruiting·Listed Feb 2022

Apply to this trial

Registry Study for Radiation Therapy Outcomes

for Neoplasms

29 locations incl. Scottsdale

Sponsor: Proton Collaborative Group

Sex: All·Age: All ages

Code: NCT01255748·Recruiting·Listed Dec 2010

Apply to this trial

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

for Prostate Cancer

6 locations incl. Little Rock

Sponsor: Proton Collaborative Group

Sex: Male·Age: 18+

Code: NCT00969111·Recruiting·Listed Aug 2009

Apply to this trial

More research sites in St Louis

Washington University School of Medicine (452 trials)
Washington University (137 trials)
Mercy Hospital Saint Louis (92 trials)
Washington University in St. Louis (81 trials)
Missouri Baptist Medical Center (80 trials)
Mercy Hospital South (80 trials)
Siteman Cancer Center-South County (70 trials)
Siteman Cancer Center at Christian Hospital (64 trials)
Mercy Infusion Center - Chippewa (26 trials)
Cardinal Glennon Children's Medical Center (24 trials)

Explore more

Paid clinical trials in St Louis, MO · Missouri clinical trials